Total Payments
$6,292
2024 Payments
$23.66
Companies
25
Transactions
134
Medicare Patients
7,734
Medicare Billing
$391,559
Payment Breakdown by Category
Travel$2,210 (35.1%)
Food & Beverage$2,173 (34.5%)
Other$1,560 (24.8%)
Consulting$334.00 (5.3%)
Education$13.89 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,210 | 4 | 35.1% |
| Food and Beverage | $2,173 | 126 | 34.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,560 | 2 | 24.8% |
| Consulting Fee | $334.00 | 1 | 5.3% |
| Education | $13.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inari Medical, Inc. | $2,028 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,002 | 14 | $0 (2021) |
| ABIOMED | $547.93 | 13 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $521.58 | 30 | $0 (2022) |
| Amgen Inc. | $204.03 | 17 | $0 (2022) |
| Abbott Laboratories | $188.63 | 9 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $181.99 | 8 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $122.50 | 9 | $0 (2021) |
| Medtronic, Inc. | $86.03 | 2 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $71.50 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.66 | 1 | Inari Medical, Inc. ($23.66) |
| 2023 | $178.31 | 4 | AstraZeneca Pharmaceuticals LP ($89.86) |
| 2022 | $2,328 | 23 | Inari Medical, Inc. ($1,981) |
| 2021 | $287.38 | 19 | Novartis Pharmaceuticals Corporation ($139.08) |
| 2020 | $368.06 | 20 | ABIOMED ($232.35) |
| 2019 | $25.31 | 2 | Abbott Laboratories ($13.64) |
| 2018 | $1,250 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($831.26) |
| 2017 | $1,830 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,158) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 2 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/10/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/18/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/12/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Cardiology | ||||||
| 12/01/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/02/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/21/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/07/2021 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 06/17/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/16/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/02/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: DIABETES | ||||||
| 05/14/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/28/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/15/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/17/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/12/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/07/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/21/2020 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/10/2020 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $49.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,152 | 2,664 | $422,464 | $91,428 |
| 2022 | 16 | 2,032 | 2,516 | $433,001 | $99,914 |
| 2021 | 16 | 1,689 | 2,067 | $461,846 | $100,212 |
| 2020 | 23 | 1,861 | 2,176 | $425,341 | $100,006 |
Total Patients
7,734
Total Services
9,423
Medicare Billing
$391,559
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 201 | 316 | $58,719 | $21,261 | 36.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 320 | 324 | $66,420 | $15,482 | 23.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 74 | $20,350 | $9,285 | 45.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 50 | 50 | $122,000 | $9,170 | 7.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 101 | $18,768 | $8,523 | 45.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 981 | 1,297 | $38,910 | $7,457 | 19.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 43 | 43 | $20,835 | $5,355 | 25.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 38 | $6,308 | $3,108 | 49.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 18 | 20 | $3,816 | $2,128 | 55.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $8,237 | $1,997 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $3,329 | $1,398 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 26 | 27 | $4,882 | $1,235 | 25.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 79 | 79 | $13,351 | $774.07 | 5.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 39 | 40 | $2,583 | $748.96 | 29.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 68 | 71 | $8,029 | $656.75 | 8.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,989 | $655.70 | 33.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 55 | 55 | $11,605 | $647.56 | 5.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 39 | 39 | $6,240 | $596.79 | 9.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 13 | 27 | $2,835 | $511.06 | 18.0% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 18 | 18 | $3,258 | $437.44 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 189 | 312 | $57,976 | $21,092 | 36.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 315 | 324 | $66,420 | $15,705 | 23.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 73 | 75 | $20,625 | $11,060 | 53.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 19 | 24 | $52,872 | $9,472 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 86 | $15,981 | $7,824 | 49.0% |
About Dr. Daniel Evans, DO
Dr. Daniel Evans, DO is a Cardiovascular Disease healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760477640.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Evans, DO has received a total of $6,292 in payments from pharmaceutical and medical device companies, with $23.66 received in 2024. These payments were reported across 134 transactions from 25 companies. The most common payment nature is "Travel and Lodging" ($2,210).
As a Medicare-enrolled provider, Evans has provided services to 7,734 Medicare beneficiaries, totaling 9,423 services with total Medicare billing of $391,559. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Columbus, OH
- Active Since 09/15/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1760477640
Products in Payments
- FLOWTRIEVER CATHETER, S (Device) $2,028
- PRADAXA (Drug) $1,968
- Impella (Device) $547.93
- ENTRESTO (Drug) $521.58
- Corlanor (Drug) $150.06
- FARXIGA (Drug) $144.88
- XARELTO (Drug) $122.50
- MICRA (Device) $86.03
- ELIQUIS (Drug) $71.98
- Confirm Rx (Device) $61.69
- Repatha (Biological) $53.97
- CardioMEMS HF System (Device) $42.93
- MRI Ready Leads (Device) $42.07
- VERQUVO (Drug) $41.82
- PRALUENT (Drug) $38.24
- BRILINTA (Drug) $37.11
- JARDIANCE (Drug) $34.06
- MULTAQ (Drug) $33.26
- INTERVENTIONAL ANGIOGRAPHY SYSTEM (Device) $29.12
- CARDIOMEMS (Device) $24.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Columbus
Gary Ansel, Md, MD
Cardiovascular Disease — Payments: $4.6M
Cardiovascular Disease $4.6M
Hunter Champion, M.d, M.D
Cardiovascular Disease — Payments: $1.7M
Cardiovascular Disease $1.7M
Steven Yakubov, Md, MD
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Mitchell Silver, Do, DO
Cardiovascular Disease — Payments: $781,405
Cardiovascular Disease $781,405
Rami Kahwash, M.d, M.D
Cardiovascular Disease — Payments: $425,557
Cardiovascular Disease $425,557
John Phillips, M.d, M.D
Cardiovascular Disease — Payments: $395,324
Cardiovascular Disease $395,324